Microba Life Sciences (ASX:MAP) Other Current Assets: A$0.00 Mil (As of Dec. 2025)


What is Microba Life Sciences Other Current Assets?

Microba Life Sciences ASX:MAP +8.11% Other Current Assets is A$0.00 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Microba Life Sciences's other current assets for the quarter that ended in Dec. 2025 was A$0.00 Mil.

Microba Life Sciences's quarterly other current assets increased from Dec. 2024 (A$0.70 Mil) to Jun. 2025 (A$1.21 Mil) but then declined from Jun. 2025 (A$1.21 Mil) to Dec. 2025 (A$0.00Mil).

Microba Life Sciences's annual other current assets declined from Jun. 2023 (A$1.60 Mil) to Jun. 2024 (A$1.01 Mil) increased from Jun. 2024 (A$1.01 Mil) to Jun. 2025 (A$1.21 Mil).


Microba Life Sciences Other Current Assets Related Terms


Microba Life Sciences Other Current Assets Historical Data

* Premium members only.

The historical data trend for Microba Life Sciences's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microba Life Sciences Other Current Assets Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Other Current Assets
1.45 1.60 1.01 1.21

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Assets Get a 7-Day Free Trial Premium Member Only -0.00 1.01 0.70 1.21 0.00

Microba Life Sciences Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of A$0.00 Mil mean?
Microba Life Sciences (ASX:MAP) has a Other Current Assets of A$0.00 Mil as of Dec. 2025. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Microba Life Sciences.
Is Microba Life Sciences' Other Current Assets too high?
Microba Life Sciences' current Other Current Assets is A$0.00 Mil.
How does Microba Life Sciences' Other Current Assets compare to TMO and DHR?
Microba Life Sciences' Other Current Assets of A$0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Medical Diagnostics & Research company?
A good Other Current Assets depends on the Medical Diagnostics & Research industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Microba Life Sciences. Microba Life Sciences's current Other Current Assets is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microba Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Microba Life Sciences (ASX:MAP) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.25, compared to a current price of A$0.04 — trading 84% below its estimated fair value. The current Other Current Assets is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Microba Life Sciences (ASX:MAP), the current Other Current Assets is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Microba Life Sciences Business Description

Address 324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.